P.C

AXTI ALERT: Bragar Eagel & Squire, P.C. is Investigating AXT, Inc. on Behalf of AXTI Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, April 5, 2024
Research, Telephone, IPO, Prospectus, P.C, IP, AXT

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against AXT, Inc. (“AXTI” or the “Company”) (NASDAQ: AXTI) on behalf of AXTI stockholders.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against AXT, Inc. (“AXTI” or the “Company”) (NASDAQ: AXTI) on behalf of AXTI stockholders.
  • Our investigation concerns whether AXTI has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Inc. As per the report, “AXTI is listed in the U.S., but its business operations are almost all conducted through a subsidiary in China.
  • AXTI wants to list that subsidiary in Shanghai to capture new financing.

AUTODESK ALERT: Bragar Eagel & Squire, P.C. is Investigating Autodesk, Inc. on Behalf of Autodesk Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, April 5, 2024
Telephone, ADSK, P.C, News

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ: ADSK) on behalf of Autodesk stockholders.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ: ADSK) on behalf of Autodesk stockholders.
  • Our investigation concerns whether Autodesk has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On April 1, 2024, Autodesk filed a Notification of Late Filing with the U.S. Securities and Exchange Commission (“SEC”).
  • The Company announced that it had launched “an internal investigation with the assistance of outside counsel and advisors” concerning its free cash flow and non-GAAP operating margins.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Ventyx, and Anavex and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, April 5, 2024
Bitcoin, Research, Bankruptcy, Psoriasis, Register, Form, Patient, Defendant, News, IPO, Crohn's disease, Security (finance), Data mining, Inflammation, Rett syndrome, Prospectus, Complaint, Hut 8, P.C, Clinical trial, MCI, Radar, File, Mergers and acquisitions, Cryptocurrency

In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).

Key Points: 
  • In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).
  • USBTC held a 50% interest in a joint venture bitcoin mining facility, located in King Mountain, Texas (the “King Mountain JV”), which was acquired in the Merger.
  • In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • For more information on the Anavex class action go to: https://bespc.com/cases/AVXL

HIRERIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against HireRight Holdings Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, April 4, 2024
Employment, Organization, Risk management, Hold, HireRight, Form, Risk, District court, Telephone, News, IPO, Alpha, Prospectus, Complaint, Publication, P.C, HRT, Court, Register, Person, Security (finance)

Investors have until June 3, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 3, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • On this news, HireRight’s stock price fell $0.88 per share, or 7.5%, to close at $10.75 per share on January 19, 2023.
  • At the time of the Complaint's filing, HireRight’s common stock continue to trade below the $19.00 per share IPO price.

ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, April 4, 2024
Interim management, Telephone, Senior, Interim, SVP, P.C, News, CFO

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME) on behalf of Zymeworks stockholders.

Key Points: 
  • NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME) on behalf of Zymeworks stockholders.
  • Our investigation concerns whether Zymeworks has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On April 1, 2024, Zymeworks disclosed that it had removed Christopher Astle (“Astle”) from the positions of Senior Vice President (“SVP”) and Chief Financial Officer (“CFO”), effective immediately.
  • On this news, Zymeworks’s stock price fell $0.64 per share, or 6.08%, to close at $9.88 per share on April 1, 2024.

ZEVRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Zevra Therapeutics, Inc. on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, April 4, 2024
Telephone, News, Bank statement, P.C, Therapy, Interim, Audit committee

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA) on behalf of Zevra stockholders.

Key Points: 
  • NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA) on behalf of Zevra stockholders.
  • Our investigation concerns whether Zevra has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • On this news, Zevra’s stock price fell $0.64 per share, or 11.03%, to close at $5.16 per share on April 1, 2024, the next trading day.

AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, April 4, 2024
Symantec Endpoint Protection, Telephone, CRL, News, NDA, CMC, Migraine, Myenteric plexus, Chemistry, P.C, Therapy, FDA, Food, Pharmaceutical industry

Our investigation concerns whether the board of directors of Axsome have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Axsome have breached their fiduciary duties to the company.
  • Axsome is a biopharmaceutical company that engages in the development of novel therapies for central nervous system disorders in the United States.
  • However, unbeknownst to investors, the Company’s preparation and eventual submission of the AXS-07 NDA was plagued with chemistry, manufacturing, and control (“CMC”) issues.
  • Then, on April 25, 2022, Axsome disclosed in a filing with the U.S. Securities and Exchange Commission that, “[o]n April 22, 2022, Axsome .

ADM ALERT: Bragar Eagel & Squire, P.C. is Investigating Archer-Daniels-Midland Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, April 4, 2024
Growth, FY, Telephone, Defendant, News, Q4, ADM, P.C

Our investigation concerns whether the board of directors of ADM have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of ADM have breached their fiduciary duties to the company.
  • As ADM was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly.
  • On January 21, 2024, ADM announced that it had placed its CFO Vikram Luther on leave effective immediately.
  • As a result, ADM delayed its Q4 and FY 2023 earnings release and withdrew its outlook for the Nutrition segment.

ALLBIRDS ALERT: Bragar Eagel & Squire, P.C. is Investigating Allbirds, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, April 3, 2024
Telephone, IPO, Defendant, P.C, Register

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Allbirds, Inc. (NASDAQ: BIRD) on behalf of long-term stockholders following a class action complaint that was filed against Allbirds on April 13, 2023 with a Class Period in connection with the Company’s November 2021 IPO and/or from November 4, 2021 to March 9, 2023.

Key Points: 
  • NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Allbirds, Inc. (NASDAQ: BIRD) on behalf of long-term stockholders following a class action complaint that was filed against Allbirds on April 13, 2023 with a Class Period in connection with the Company’s November 2021 IPO and/or from November 4, 2021 to March 9, 2023.
  • Our investigation concerns whether the board of directors of Allbirds have breached their fiduciary duties to the company.
  • The complaint filed in this class action alleges that in the Registration Statement and throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
  • There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NYCB, InMode, Innodata, and Fox Factory and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, April 3, 2024
Research, Class Action, Signature, Growth, ACL, Food and Drug Administration, Defendant, Dermatology, News, AI, New York Community Bank, Nature, NYCB, Silicon, Complaint, P.C, Goldengate, Research and development, Fox Factory, Assumption, Confidentiality, Injury, Category, Wolfpack, Dentist, FDA, Marketing

NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.

Key Points: 
  • NYCB is a large commercial-real estate lender in the New York City market area, where it specializes in rent-regulated, non-luxury apartment buildings.
  • On January 31, 2024, before the market opened, NYCB announced its fiscal fourth quarter 2023 financial results.
  • The complaint further alleges that when these misleading statements and omissions about Fox Factory’s business reached the market, investors were harmed significantly.
  • For more information on the Fox Factory class action go to: https://bespc.com/cases/FOXF